EurekaMag.com logo
+ Site Statistics
References:
52,725,316
Abstracts:
28,411,598
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Demonstration of the stability of freeze dried Brucella melitensis Rev. 1 and Brucella abortus S19 vaccines at different temperatures


Pendik Veteriner Mikrobiyoloji Dergisi 26(1): 45-54
Demonstration of the stability of freeze dried Brucella melitensis Rev. 1 and Brucella abortus S19 vaccines at different temperatures
Lyophilized full-dose B. melitensis Rev. 1 (1.7+or-0.601 x 109), reduced-dose B. melitensis Rev. 1 (5.9+or-0.875 x 109) and full-dose B. abortus S19 vaccines (50+or-7, 430 x 109) produced in fermenters in a liquid medium were maintained at five different storage temperatures (-20 degrees C, -10 degrees C, +4 degrees C, +20 degrees C and +37 degrees C) for 52 weeks and their viability determined periodically.


Accession: 002590361



Related references

Comparison of the efficacy of Brucella abortus strain RB51 and Brucella melitensis Rev. 1 live vaccines against experimental infection with Brucella melitensis in pregnant ewes. Revue Scientifique et Technique 20(3): 741-747, 2001

Brucella suis s2 brucella melitensis rev. 1 and brucella abortus s19 living vaccines residual virulence and immunity induced against three brucella spp challenge strains in mice. Vaccine 8(5): 462-468, 1990

Brucella suis S2, Brucella melitensis Rev.1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice. Vaccine 8(5): 462-468, 1990

Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice. Vaccine 8(5): 462-468, 1990

Phage typing reactions on brucella species brucella abortus brucella neotomae brucella suis brucella melitensis brucella ovis brucella canis. Applied Microbiology 16(8): 1179-1190, 1968

Vaccination with Brucella abortus rough mutant RB51 protects BALB/c mice against virulent strains of Brucella abortus, Brucella melitensis, and Brucella ovis. Infection and Immunity 62(11): 4990-4996, 1994

Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model. Infection and Immunity 71(6): 3261-3271, 2003

Endo toxin from brucella some structural and biological properties abstract mouse rabbit brucella abortus brucella melitensis lipid carbohydrated protein complex heat stability enz pronase digestion. Bacteriological Proceedings 69: 71, 1969

Morphological, biochemical and serological characters of a strain of Brucella canis in comparison to strains of Brucella abortus, Brucella melitensis and Brucella ovis. Archivio veterinario italiano, 29(5-6): 149-151, 1978

Occurrence of antibodies against brucella brucella abortus brucella melitensis brucella canis in serum samples of cloven hoofed game of west germany. Zeitschrift fuer Jagdwissenschaft 27(3): 191-195, 1981